Clinical Trial Update: Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for vinorelbine in relapsed platinum-resistant or refractory high-grade serous, endometrioid, or undifferentiated primar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Vinorelbine (Vinorelbine)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: UNKNOWN